Trials / Completed
CompletedNCT02221167
Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes
Rx Milk: Donor Milk Supplementation to Increase Breastfeeding Duration & Exclusivity, a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Laura Kair · Academic / Other
- Sex
- All
- Age
- 24 Hours – 48 Hours
- Healthy volunteers
- Not accepted
Summary
This study is a randomized controlled trial seeking to determine whether supplementing infants at risk for excessive neonatal weight loss with a small volume of human donor milk prophylactically in the first 1-3 days of life, before maternal mature milk production (before mom's milk "comes in") will decrease the incidence of formula use at 1 week and 1, 2, and 3 months of life and increase the rate of exclusive breastfeeding in this high-risk population. We hypothesize that supplementation of term infants who have lost greater than or equal to 5% birth weight by 36 hours of age with a small volume of donor breast milk following feeds, until mature milk production, will result in decreased supplemental formula use at 1 week and increased exclusive as well as any breastfeeding at 1 week and 1, 2, and 3 months. This study's specific aims are to compare the effectiveness of encouraging in-hospital exclusive breastfeeding with offering early small-volume donor milk supplementation in a population of infants at risk for excessive neonatal weight loss with goals of 1) decreasing the incidence of formula supplementation at 1 week of life and 2) improving breastfeeding duration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Donor Milk | breastfeeding plus 10 ml of donor milk by syringe after each breastfeeding until mother's milk "comes in." |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-07-01
- Completion
- 2016-09-01
- First posted
- 2014-08-20
- Last updated
- 2018-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02221167. Inclusion in this directory is not an endorsement.